Performance comparison of the Cobas® Liat® and Cepheid® GeneXpert® systems on SARS-CoV-2 detection in nasopharyngeal swab and posterior oropharyngeal saliva-Reference-Cited by-同舟云学术

Performance comparison of the Cobas® Liat® and Cepheid® GeneXpert® systems on SARS-CoV-2 detection in nasopharyngeal swab and posterior oropharyngeal saliva

Published:2021-04-28 Issue:5 Volume:21 Page:515-518
ISSN:1473-7159
Container-title:Expert Review of Molecular Diagnostics
language:en
Short-container-title:Expert Review of Molecular Diagnostics

Author:

Tsang Hin Fung¹²,Leung Wai Ming Stanley¹,Chan Lawrence Wing Chi²,Cho William Chi Shing³^ORCID,Wong Sze Chuen Cesar²

Affiliation:

1. Department of Clinical Laboratory and Pathology, Hong Kong Adventist Hospital, Hong Kong Special Administrative Region

2. Department of Health Technology and Informatics, Hong Kong Polytechnic University, Hong Kong Special Administrative Region

3. Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong Special Administrative Region

Publisher

Informa UK Limited

Subject

Genetics,Molecular Biology,Molecular Medicine,Pathology and Forensic Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737159.2021.1919513

Reference15 articles.

1. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China

2. Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection

3. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

4. Centers for Disease Control and Prevention. Coronavirus Disease 2019. Laboratories; [cited 2020 Apr 25]. Available from: https://www.cdc.gov/coronavirus/2019-nCoV/lab/index.html

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical performance of the Roche Cobas Liat SARS-CoV-2 & influenza A/B assay: A systematic review and meta-analysis;Journal of Clinical Virology;2024-10

2. Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies;International Journal of Molecular Sciences;2024-07-26

3. Multiplex CLIA-waived point-of-care tests for SARS-CoV-2, influenza A and B, ± other respiratory pathogens: A systematic review;Journal of the American Pharmacists Association;2024-07

4. UbiNAAT: a multiplexed point-of-care nucleic acid diagnostic platform for rapid at-home pathogen detection;Lab on a Chip;2024

5. Comparison of “hock-a-loogie” saliva versus nasopharyngeal and oropharyngeal swabs for detecting common respiratory pathogens;Heliyon;2023-10